Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Immunol ; 36(9): 2347-58, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16909431

ABSTRACT

Recent evidence suggests that the functional status of T cells activated independently from their TCR differs substantially from classical MHC-restricted T cells. Here, we show that TCR-independent, short-term stimulation via the common gamma-chain of the IL-2/IL-15 receptor induces non-MHC-restricted cytotoxicity and sustained cytokine secretion in purified CD4+ or CD8+ T cells. NK-like cytotoxicity is directed against MHC class I-negative targets and can be inhibited by classical and non-classical HLA class I molecules. Known inhibitory receptors, such as CD85j (ILT2) and leukocyte-associated Ig-like receptor-1, are not responsible for this HLA-mediated inhibition. NK-like cytotoxicity can be costimulated by NKG2D (CD314) triggering, but 2B4 (CD244) and DNAM-1 (CD226) are not involved. NK-like T cells display an activated phenotype and secrete various cytokines, including IFN-gamma, TNF-alpha, IL-5, IL-13 and MIP-1beta. Under normal conditions, HLA class I-mediated inhibition may function as a safety mechanism to prevent unbalanced cytokine production and effector killing mechanisms by T cells that were activated independently from their TCR. Non-MHC-restricted activity represents a functional status rather than a property of distinct T cell subpopulations. Thus, cytokine-induced, non-MHC-restricted T cells may be relevant in immune responses against tumors showing aberrant MHC expression through their capacities of cytokine production and direct tumor cell eradication.


Subject(s)
Cytokines/biosynthesis , Cytotoxicity, Immunologic , Histocompatibility Antigens Class I/immunology , Major Histocompatibility Complex/immunology , Receptors, Antigen, T-Cell/immunology , T-Lymphocytes/immunology , Cytokines/immunology , Humans , Lymphocyte Activation/immunology , NK Cell Lectin-Like Receptor Subfamily K , Receptors, Immunologic/immunology , Receptors, Interleukin-2/immunology , Receptors, Natural Killer Cell
2.
Int J Cancer ; 106(6): 905-12, 2003 Oct 10.
Article in English | MEDLINE | ID: mdl-12918068

ABSTRACT

Among tumor-infiltrating lymphocytes (TILs) directly isolated from renal cell carcinomas (RCCs), we found substantial numbers of natural killer (NK) cells in most tumor tissues. They could be identified reliably in situ with an antibody directed against the activating receptor (AR) NKp46 that is exclusively expressed by all NK cells. NK-enriched TILs (NK-TILs) showed cytotoxicity against major histocompatibility complex (MHC) class I-negative cell lines. The ability to detect lysis of target cells was dependent on the percentage of NK cells within the TILs, and cytotoxicity was only observed after overnight activation with low-dose interleukin-2 (IL-2). Infiltrating NK cells were found to express various inhibitory receptors (IRs); among these the CD94/NKG2A receptor complex was overrepresented compared to the autologous peripheral blood mononuclear cell (PBMC) population. Other IRs were underrepresented, indicating that NK subpopulations vary in their tumor-infiltrating capacity. IRs expressed by NK-TILs are functional since receptor engagement with MHC class I ligands presented by human leukocyte antigen (HLA)-transfected target cell lines was able to inhibit NK-mediated cytotoxicity. NK-TILs were also able to lyse autologous or allogeneic tumor cell lines in vitro. This activity correlated with low HLA class I surface expression since lysis could be inhibited by interferon (IFN)-gamma-expressing RCC transductants that displayed a higher surface density of HLA class I molecules. Therefore, NK cells infiltrating tumor tissues have an inherent ability to recognize transformed cells, but they require cytokine activation and are sensitive to inhibition by IR ligands.


Subject(s)
Antigens, CD/metabolism , Carcinoma, Renal Cell/immunology , HLA Antigens/metabolism , Histocompatibility Antigens Class I/pharmacology , Kidney Neoplasms/immunology , Killer Cells, Natural/immunology , Lymphocytes, Tumor-Infiltrating , Carcinoma, Renal Cell/pathology , Cytotoxicity, Immunologic , Histocompatibility Antigens Class I/immunology , Humans , Interleukin-2/metabolism , Isoantigens/immunology , Isoantigens/pharmacology , Kidney Neoplasms/pathology , Killer Cells, Lymphokine-Activated/immunology , Lymphocyte Activation , Receptors, Immunologic/metabolism
3.
J Biol Chem ; 277(46): 44475-84, 2002 Nov 15.
Article in English | MEDLINE | ID: mdl-12191999

ABSTRACT

The ability to rescue viable prostate precursor tissue from retinoblastoma-deficient (Rb-/-) fetal mice has allowed for the isolation and characterization of the first Rb-/- prostate epithelial cell line. This cell line, designated Rb-/-PrE, was utilized for experiments examining the consequences of Rb loss on an epithelial population. These findings demonstrated that Rb deletion has no discernible effect on prostatic histodifferentiation in Rb-/-PrE cultures. When Rb-/-PrE cells were recombined with embryonic rat urogenital mesenchyme and implanted into athymic male, nude mouse hosts, the recombinants developed into fully differentiated and morphologically normal prostate tissue. The Rb-/-PrE phenotype was characterized by serum independence in culture and immortality in vivo, when compared with wild type controls. Cell cycle analysis revealed elevated S phase DNA content accompanied by increased expression of cyclin E1 and proliferating cell nuclear antigen. Rb-/-PrE cultures also exhibited a diminished ability to growth arrest under high density culture conditions. We believe that the development of Rb-/- prostate tissue and cell lines has provided a unique experimental platform with which to investigate the consequences of Rb deletion in epithelial cells under various physiological conditions. Additionally, the development of this technology will allow similar studies in other tissues and cell populations rescued from Rb-/- fetuses.


Subject(s)
Epithelial Cells/cytology , Growth Substances/metabolism , Retinoblastoma Protein/genetics , Retinoblastoma Protein/physiology , Animals , Cell Cycle , Cell Differentiation , Cell Division , Cell Line , Culture Media, Serum-Free/pharmacology , Cyclin E/biosynthesis , Gene Deletion , Genotype , Homozygote , Immunohistochemistry , Karyotyping , Kinetics , Male , Mice , Mice, Nude , Nucleic Acid Hybridization , Phenotype , Proliferating Cell Nuclear Antigen/metabolism , Prostate/pathology , Prostatic Neoplasms/metabolism , Recombination, Genetic , Retinoblastoma Protein/biosynthesis , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...